Evoq Remedies Ratios

Evoq Remedies Ltd Ratios

The Evoq Remedies Ltd Ratios page provides a complete fundamental analysis of Evoq Remedies Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Evoq Remedies Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Evoq Remedies Ltd (NSE: , BSE: 543500) is currently trading at ₹2.30, with a market capitalization of ₹0. As a major player in the Health technology sector and Pharmaceuticals: major industry, Evoq Remedies Ltd remains a key stock for fundamental analysis using Evoq Remedies Ltd Ratios.

Evoq Remedies Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Evoq Remedies Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Evoq Remedies Ltd Ratios.

Historically, the Evoq Remedies Ltd P/E ratio has shown strong fluctuations:

The decline in Evoq Remedies Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Evoq Remedies Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Evoq Remedies Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Evoq Remedies Ltd P/S ratio currently stands at 0, an important part of Evoq Remedies Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Evoq Remedies Ltd P/S ratio indicates cautious market sentiment.

Evoq Remedies Ltd Price to Cash Flow Ratio (P/CF)

The Evoq Remedies Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Evoq Remedies Ltd Price to Cash Flow Ratio:

The declining Evoq Remedies Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Evoq Remedies Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Evoq Remedies Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Evoq Remedies Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Evoq Remedies Ltd EV/EBITDA ratio is currently 0, a key metric in Evoq Remedies Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Evoq Remedies Ltd EV/EBITDA indicates balanced valuation.

Evoq Remedies Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Evoq Remedies Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Evoq Remedies Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Evoq Remedies Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Evoq Remedies Ltd Ratios Analysis Summary

The Evoq Remedies Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Evoq Remedies Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Evoq Remedies Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.